Form D · Other Health Care
North Texas Renal Management XII, LLC
Dallas, X1 · CIK 0002020966
Offering snapshot reported Apr 25, 2024 · SEC filing
- Reported sold
- $628K Offering amount: $1.63M
- Investors reported
- 42 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 17, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2024 | Initial | $627,632 | No comparison | 42 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-511642
Source: Form D, filed Apr 25, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven M. Gieser, M.D. | Director, Executive |
| Ali M. Khalil, M.D. | Director |
| Jyothsna M. Kodali, M.D. | Director, Executive |
| Daniel M. Richey, D.O. | Director |
| Geoffrey Walker, M.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1505 Lbj Freeway Suite 700
Dallas, X1, 75234
Dallas, X1, 75234